{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:49Z","timestamp":1787020729034,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The secreted protein augurin, the product of the tumor suppressor gene\n                    <jats:italic>Ecrg4<\/jats:italic>\n                    , has been identified as a peptide hormone in the human proteome in 2007. Since then, a number of studies have been carried out to highlight its structure and processing and its potential roles in physiopathology. Although augurin has been shown to be implicated in a variety of processes, ranging from tumorigenesis, inflammation and infection to neural stem cell proliferation, hypothalamo-pituitary adrenal axis regulation and osteoblast differentiation, the molecular mechanisms of its biological effects and the signaling pathways it regulates are still poorly characterized. Here we provide a comprehensive overview of augurin-dependent signal transduction pathways. Because of their secreted nature and the potential to be manipulated pharmacologically, augurin and its derived peptides represent attractive targets for diagnostic development and discovery of new therapeutic agents for the human diseases resulting from the deregulation of the signaling cascades they modulate. From this perspective, the characterization of the precise nature of augurin derived peptides and the identification of the receptor(s) on the cell surface conveying augurin signaling to downstream effectors are crucial to develop agonists and antagonists for this protein.\n                  <\/jats:p>","DOI":"10.1186\/s12964-023-01090-8","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T05:03:23Z","timestamp":1681189403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Complex and pleiotropic signaling pathways regulated by the secreted protein augurin"],"prefix":"10.1186","volume":"21","author":[{"given":"Margaux","family":"Richter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Lalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"3","key":"1090_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1101\/gr.5755407","volume":"17","author":"O Mirabeau","year":"2007","unstructured":"Mirabeau O, Perlas E, Severini C, Audero E, Gascuel O, Possenti R, et al. Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res. 2007;17(3):320\u20137.","journal-title":"Genome Res"},{"issue":"4","key":"1090_CR2","first-page":"254","volume":"20","author":"T Su","year":"1998","unstructured":"Su T, Liu H, Lu S. Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi. 1998;20(4):254\u20137.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"1","key":"1090_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2045-8118-8-6","volume":"8","author":"AM Gonzalez","year":"2011","unstructured":"Gonzalez AM, Podvin S, Lin SY, Miller MC, Botfield H, Leadbeater WE, et al. Ecrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury. Fluids Barriers CNS. 2011;8(1):6.","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"1090_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00441-012-1396-6","volume":"348","author":"X Dang","year":"2012","unstructured":"Dang X, Podvin S, Coimbra R, Eliceiri B, Baird A. Cell specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4. Cell Tissue Res. 2012;348(3):505\u201314.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"1090_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.gene.2009.08.015","volume":"448","author":"YH Huh","year":"2009","unstructured":"Huh YH, Ryu JH, Shin S, Lee DU, Yang S, Oh KS, et al. Esophageal cancer related gene 4 (ECRG4) is a marker of articular chondrocyte differentiation and cartilage destruction. Gene. 2009;448(1):7\u201315.","journal-title":"Gene"},{"issue":"8","key":"1090_CR6","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1021\/pr900248y","volume":"8","author":"JA Dowell","year":"2009","unstructured":"Dowell JA, Johnson JA, Li L. Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics. J Proteome Res. 2009;8(8):4135\u201343.","journal-title":"J Proteome Res"},{"key":"1090_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14789\/pjmj.48.216","volume":"48","author":"N Tachibana","year":"2002","unstructured":"Tachibana N, Fujimaki T, Nakamura S, Funaki T, Murakami A. Gene expression profile study of corneal endothelium. Juntendo Med J. 2002;48:216\u201325.","journal-title":"Juntendo Med J"},{"key":"1090_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq031","author":"T Horiuchi","year":"2010","unstructured":"Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatol Oxf Engl. 2010. https:\/\/doi.org\/10.1093\/rheumatology\/keq031.","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"1090_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/me.2010-0389","volume":"25","author":"A Ozawa","year":"2011","unstructured":"Ozawa A, Lick AN, Lindberg I. Processing of proaugurin is required to suppress proliferation of tumor cell lines. Mol Endocrinol. 2011;25(5):776\u201384.","journal-title":"Mol Endocrinol"},{"key":"1090_CR10","unstructured":"Feige Jj, Baird A. Crinopexy: extracellular regulation of growth factor action. Kidney Int Suppl. 1995;49."},{"issue":"8","key":"1090_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/pin.12079","volume":"63","author":"J Matsuzaki","year":"2013","unstructured":"Matsuzaki J, Torigoe T, Hirohashi Y, Tamura Y, Asanuma H, Nakazawa E, et al. Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells. Pathol Int. 2013;63(8):391\u20137.","journal-title":"Pathol Int"},{"issue":"3","key":"1090_CR12","first-page":"257","volume":"33","author":"MX Bi","year":"2001","unstructured":"Bi MX, Han WD, Lu SX. Using lab on-line to clone and identify the esophageal cancer related gene 4. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochim Biophys Sin. 2001;33(3):257\u201361.","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochim Biophys Sin"},{"issue":"3","key":"1090_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/01902148.2014.983282","volume":"41","author":"S Kao","year":"2015","unstructured":"Kao S, Shaterian A, Cauvi DM, Dang X, Chun HB, De Maio A, et al. Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung. Exp Lung Res. 2015;41(3):162\u201372.","journal-title":"Exp Lung Res"},{"issue":"16","key":"1090_CR14","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci. 2004;101(16):6062\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1090_CR15","doi-asserted-by":"crossref","unstructured":"Roberton A, Gonzalez AM, Stopa E, Leadbeater W, Coimbra R, Johanson C, et al. Immunohistochemical evidence that Argillin, the product of the ECRG4 gene, encodes a novel neuroendocrine peptide. Endocr Abstr. 2009;19.","DOI":"10.1210\/endo-meetings.2010.PART1.P5.P1-214"},{"issue":"18","key":"1090_CR16","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1073\/pnas.0911446107","volume":"107","author":"Y Kujuro","year":"2010","unstructured":"Kujuro Y, Suzuki N, Kondo T. Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci. 2010;107(18):8259\u201364.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"1090_CR17","first-page":"dev168120","volume":"146","author":"Y Nakatani","year":"2019","unstructured":"Nakatani Y, Kiyonari H, Kondo T. Ecrg4 deficiency extends the replicative capacity of neural stem cells in a Foxg1-dependent manner. Dev Camb Engl. 2019;146(4):dev168120.","journal-title":"Dev Camb Engl"},{"issue":"2","key":"1090_CR18","first-page":"107","volume":"64","author":"S Podvin","year":"2015","unstructured":"Podvin S, Dang X, Meads M, Kurabi A, Costantini T, Eliceiri BP, et al. Esophageal cancer-related gene-4 (ECRG4) interactions with the innate immunity receptor complex. Inflamm Res Off J Eur Histamine Res Soc Al. 2015;64(2):107\u201318.","journal-title":"Inflamm Res Off J Eur Histamine Res Soc Al"},{"issue":"9","key":"1090_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024609","volume":"6","author":"S Podvin","year":"2011","unstructured":"Podvin S, Gonzalez AM, Miller MC, Dang X, Botfield H, Donahue JE, et al. Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury. PLoS ONE. 2011;6(9): e24609.","journal-title":"PLoS ONE"},{"issue":"4","key":"1090_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061394","volume":"8","author":"A Kurabi","year":"2013","unstructured":"Kurabi A, Pak K, Dang X, Coimbra R, Eliceiri BP, Ryan AF, et al. Ecrg4 attenuates the inflammatory proliferative response of mucosal epithelial cells to infection. PLoS ONE. 2013;8(4): e61394.","journal-title":"PLoS ONE"},{"key":"1090_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jss.2012.10.772","volume":"179","author":"A Shaterian","year":"2013","unstructured":"Shaterian A, Kao S, Cauvi D, DeMaio A, Chun H, Costantini T, et al. Identification of Ecrg4 and its cytokine-like protein product in lung: differential down regulation after exploratory laparotomy. J Surg Res. 2013;179:339.","journal-title":"J Surg Res"},{"issue":"5","key":"1090_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1189\/jlb.1011503","volume":"91","author":"A Baird","year":"2012","unstructured":"Baird A, Coimbra R, Dang X, Lopez N, Lee J, Krzyzaniak M, et al. Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages. J Leukoc Biol. 2012;91(5):773\u201381.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"1090_CR23","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ijc.24513","volume":"125","author":"LW Li","year":"2009","unstructured":"Li LW, Yu XY, Yang Y, Zhang CP, Guo LP, Lu SH. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer. 2009;125(7):1505\u201313.","journal-title":"Int J Cancer"},{"issue":"6","key":"1090_CR24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3748\/wjg.v9.i6.1174","volume":"9","author":"CM Yue","year":"2003","unstructured":"Yue CM, Deng DJ, Bi MX, Guo LP, Lu SH. Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol. 2003;9(6):1174\u20138.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1090_CR25","doi-asserted-by":"publisher","first-page":"9111","DOI":"10.1007\/s13277-015-4775-2","volume":"37","author":"Z Cai","year":"2016","unstructured":"Cai Z, Liang P, Xuan J, Wan J, Guo H. ECRG4 as a novel tumor suppressor gene inhibits colorectal cancer cell growth in vitro and in vivo. Tumor Biol. 2016;37(7):9111\u201320.","journal-title":"Tumor Biol"},{"issue":"1","key":"1090_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1756-9966-29-89","volume":"29","author":"W Li","year":"2010","unstructured":"Li W, Liu X, Zhang B, Qi D, Zhang L, Jin Y, et al. Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res CR. 2010;29(1):89.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"1090_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/1471-2407-9-447","volume":"9","author":"S G\u00f6tze","year":"2009","unstructured":"G\u00f6tze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, et al. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer. 2009;9:447.","journal-title":"BMC Cancer"},{"issue":"11","key":"1090_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027656","volume":"6","author":"R Sabatier","year":"2011","unstructured":"Sabatier R, Finetti P, Adelaide J, Guille A, Borg JP, Chaffanet M, et al. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS ONE. 2011;6(11): e27656.","journal-title":"PLoS ONE"},{"issue":"5","key":"1090_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/07357900802620794","volume":"27","author":"DK Vanaja","year":"2009","unstructured":"Vanaja DK, Ehrich M, Van den Boom D, Cheville JC, Karnes RJ, Tindall DJ, et al. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest. 2009;27(5):549\u201360.","journal-title":"Cancer Invest"},{"issue":"4","key":"1090_CR30","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.3892\/mmr.2015.4059","volume":"12","author":"J Jia","year":"2015","unstructured":"Jia J, Dai S, Sun X, Sang Y, Xu Z, Zhang J, Cui X, Song J, Guo X. A preliminary study of the effect of ECRG4 overexpression on the proliferation and apoptosis of human laryngeal cancer cells and the underlying mechanisms. Mol Med Rep. 2015;12(4):5058\u201364.","journal-title":"Mol Med Rep"},{"issue":"5","key":"1090_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/neuonc\/nou302","volume":"17","author":"J Lee","year":"2015","unstructured":"Lee J, Dang X, Borboa A, Coimbra R, Baird A, Eliceiri BP. Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation. Neuro-Oncology. 2015;17(5):685\u201396.","journal-title":"Neuro-Oncology"},{"issue":"1","key":"1090_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12967-022-03446-z","volume":"20","author":"Z Xie","year":"2022","unstructured":"Xie Z, Li W, Ai J, Xie J, Zhang X. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K\/AKT\/mTOR signaling pathway. J Transl Med. 2022;20(1):264.","journal-title":"J Transl Med"},{"issue":"6","key":"1090_CR33","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3892\/ol.2013.1298","volume":"5","author":"T Xu","year":"2013","unstructured":"Xu T, Xiao D, Zhang X. ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo. Oncol Lett. 2013;5(6):1921\u20136.","journal-title":"Oncol Lett"},{"issue":"4","key":"1090_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/GICTT.S49085","volume":"2014","author":"A Baird","year":"2014","unstructured":"Baird A, Lee J, Podvin S, Kurabi A, Dang X, Coimbra R, et al. Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy. Gastrointest Cancer Targets Ther. 2014;2014(4):131\u201342.","journal-title":"Gastrointest Cancer Targets Ther"},{"issue":"5","key":"1090_CR35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11684-018-0637-9","volume":"13","author":"X Qin","year":"2019","unstructured":"Qin X, Zhang P. ECRG4: a new potential target in precision medicine. Front Med. 2019;13(5):540\u20136.","journal-title":"Front Med"},{"issue":"8","key":"1090_CR36","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1476-5381.2010.00655.x","volume":"159","author":"J Tadross","year":"2010","unstructured":"Tadross J, Patterson M, Suzuki K, Beale K, Boughton C, Smith K, et al. Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats. Br J Pharmacol avr. 2010;159(8):1663\u201371.","journal-title":"Br J Pharmacol avr"},{"issue":"3","key":"1090_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ctd2.113","volume":"2","author":"C Ruggiero","year":"2022","unstructured":"Ruggiero C, Durand N, Jarjat M, Barhanin J, Ghirardello EJ, Dack MRG, et al. The secreted protein augurin is a novel modulator of canonical Wnt signalling involved in osteoblast differentiation. Clin Transl Discov. 2022;2(3): e113.","journal-title":"Clin Transl Discov"},{"issue":"1","key":"1090_CR38","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):1\u20139.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1090_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1(4): a000034.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"20","key":"1090_CR40","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1242\/jcs.02579","volume":"118","author":"PN Moynagh","year":"2005","unstructured":"Moynagh PN. The NF-\u03baB pathway. J Cell Sci. 2005;118(20):4589\u201392.","journal-title":"J Cell Sci"},{"issue":"2","key":"1090_CR41","first-page":"107","volume":"64","author":"S Podvin","year":"2015","unstructured":"Podvin S, Dang X, Meads M, Kurabi A, Costantini T, Eliceiri BP, et al. Esophageal cancer related gene-4 (ECRG4) interactions with the innate immunity receptor complex. Inflamm Res Off J Eur Histamine Res Soc Al. 2015;64(2):107\u201318.","journal-title":"Inflamm Res Off J Eur Histamine Res Soc Al"},{"issue":"24","key":"1090_CR42","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1007\/s00018-019-03159-5","volume":"76","author":"X Dang","year":"2019","unstructured":"Dang X, Coimbra R, Mao L, Podvin S, Li X, Yu H, et al. Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4. Cell Mol Life Sci. 2019;76(24):5027\u201339.","journal-title":"Cell Mol Life Sci"},{"key":"1090_CR43","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1038\/s41598-018-22440-4","volume":"8","author":"T Moriguchi","year":"2018","unstructured":"Moriguchi T, Takeda S, Iwashita S, Enomoto K, Sawamura T, Koshimizu U, et al. Ecrg4 peptide is the ligand of multiple scavenger receptors. Sci Rep. 2018;8:4048.","journal-title":"Sci Rep"},{"key":"1090_CR44","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3389\/fgene.2020.00846","volume":"11","author":"X Liang","year":"2020","unstructured":"Liang X, Gao J, Wang Q, Hou S, Wu C. ECRG4 represses cell proliferation and invasiveness via NFIC\/OGN\/NF-\u03baB signaling pathway in bladder cancer. Front Genet. 2020;11:846.","journal-title":"Front Genet"},{"key":"1090_CR45","doi-asserted-by":"publisher","first-page":"852383","DOI":"10.3389\/fonc.2022.852383","volume":"12","author":"Q Luo","year":"2022","unstructured":"Luo Q, Du R, Liu W, Huang G, Dong Z, Li X. PI3K\/Akt\/mTOR signaling pathway: role in esophageal squamous cell carcinoma, regulatory mechanisms and opportunities for targeted therapy. Front Oncol. 2022;12:852383.","journal-title":"Front Oncol"},{"key":"1090_CR46","doi-asserted-by":"publisher","first-page":"10639","DOI":"10.2147\/OTT.S222967","volume":"12","author":"T Xu","year":"2019","unstructured":"Xu T, Zhang R, Dong M, Zhang Z, Li H, Zhan C, et al. Osteoglycin (OGN) inhibits cell proliferation and invasiveness in breast cancer via PI3K\/Akt\/mTOR signaling pathway. OncoTargets Ther. 2019;12:10639\u201350.","journal-title":"OncoTargets Ther"},{"key":"1090_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153385","volume":"220","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Dashti S, Hussen BM, Farsi M, Taheri M. BCYRN1: an oncogenic lncRNA in diverse cancers. Pathol Res Pract. 2021;220: 153385.","journal-title":"Pathol Res Pract"},{"key":"1090_CR48","doi-asserted-by":"crossref","unstructured":"Hu T, Lu YR. BCYRN1, a c-MYC-activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer. Cancer Cell Int. 1 avr 2015;15:36.","DOI":"10.1186\/s12935-015-0183-3"},{"key":"1090_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.05.012","volume":"62","author":"W Huang","year":"2019","unstructured":"Huang W, Zhou R, Mao L, Deng C, Dang X. Esophageal cancer related gene-4 inhibits the migration and proliferation of oral squamous cell carcinoma through BC200 lncRNA\/MMP-9 and -13 signaling pathway. Cell Signal. 2019;62: 109327.","journal-title":"Cell Signal"},{"issue":"3","key":"1090_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.critrevonc.2013.12.012","volume":"90","author":"KH Khan","year":"2014","unstructured":"Khan KH, Blanco-Codesido M, Molife LR. Cancer therapeutics: targeting the apoptotic pathway. Crit Rev Oncol Hematol. 2014;90(3):200\u201319.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"1090_CR51","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/carcin\/bgs118","volume":"33","author":"J Matsuzaki","year":"2012","unstructured":"Matsuzaki J, Torigoe T, Hirohashi Y, Kamiguchi K, Tamura Y, Tsukahara T, et al. ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells. Carcinogenesis. 2012;33(5):996\u20131003.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1090_CR52","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.3892\/ol.2017.6616","volume":"14","author":"S Ge","year":"2017","unstructured":"Ge S, Xu Y, Wang H, Sun Y, Tian X, Cao Z, et al. Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinoma. Oncol Lett sept. 2017;14(3):3689\u201396.","journal-title":"Oncol Lett sept"},{"issue":"5307","key":"1090_CR53","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","volume":"275","author":"PJ Morin","year":"1997","unstructured":"Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of \u03b2-catenin-Tcf signaling in colon cancer by mutations in \u03b2-catenin or APC. Science. 1997;275(5307):1787\u201390.","journal-title":"Science"},{"issue":"4999","key":"1090_CR54","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/science.1848370","volume":"251","author":"KW Kinzler","year":"1991","unstructured":"Kinzler KW, Nilbert MC, Vogelstein B, Bryan TM, Levy DB, Smith KJ, et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science. 1991;251(4999):1366\u201370.","journal-title":"Science"},{"issue":"5020","key":"1090_CR55","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.1651563","volume":"253","author":"I Nishisho","year":"1991","unstructured":"Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991;253(5020):665\u20139.","journal-title":"Science"},{"issue":"1","key":"1090_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"JL Stamos","year":"2013","unstructured":"Stamos JL, Weis WI. The \u03b2-catenin destruction complex. Cold Spring Harb Perspect Biol. 2013;5(1): a007898.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"22","key":"1090_CR57","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1093\/hmg\/dds333","volume":"21","author":"A El Wakil","year":"2012","unstructured":"El Wakil A, Bandulik S, Guy N, Bendahhou S, Zennaro MC, Niehrs C, et al. Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex. Hum Mol Genet. 2012;21(22):4922\u20139.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1090_CR58","first-page":"2458","volume":"59","author":"A Porzionato","year":"2015","unstructured":"Porzionato A, Rucinski M, Macchi V, Sarasin G, Malendowicz LK, De Caro R. ECRG4 expression in normal rat tissues: expression study and literature review. Eur J Histochem EJH. 2015;59(2):2458.","journal-title":"Eur J Histochem EJH"},{"key":"1090_CR59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mce.2016.09.003","volume":"441","author":"E Pignatti","year":"2017","unstructured":"Pignatti E, Leng S, Carlone DL, Breault DT. Regulation of zonation and homeostasis in the adrenal cortex. Mol Cell Endocrinol. 2017;441:146\u201355.","journal-title":"Mol Cell Endocrinol"},{"key":"1090_CR60","doi-asserted-by":"publisher","first-page":"12751","DOI":"10.1038\/ncomms12751","volume":"7","author":"C Drelon","year":"2016","unstructured":"Drelon C, Berthon A, Sahut-Barnola I, Mathieu M, Dumontet T, Rodriguez S, et al. PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development. Nat Commun. 2016;7:12751.","journal-title":"Nat Commun"},{"key":"1090_CR61","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fimmu.2016.00378","volume":"7","author":"B Ma","year":"2016","unstructured":"Ma B, Hottiger MO. Crosstalk between Wnt\/\u03b2-catenin and NF-\u03baB signaling pathway during inflammation. Front Immunol. 2016;7:378.","journal-title":"Front Immunol"},{"issue":"2","key":"1090_CR62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10616-022-00520-8","volume":"74","author":"Z Yang","year":"2022","unstructured":"Yang Z, Ye X, Zhang Y, Huang Y, Chen J, Zeng Y, et al. ECRG4 acts as a tumor suppressor in nasopharyngeal carcinoma by suppressing the AKT\/GSK3\u03b2\/\u03b2-catenin signaling pathway. Cytotechnology. 2022;74(2):231\u201343.","journal-title":"Cytotechnology"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01090-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01090-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01090-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T11:32:25Z","timestamp":1681731145000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01090-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1090"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01090-8","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"23 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"69"}}